Form 8-K - Current report:
SEC Accession No. 0001193125-25-115946
Filing Date
2025-05-08
Accepted
2025-05-08 16:06:09
Documents
19
Period of Report
2025-05-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d788679d8k.htm   iXBRL 8-K 32225
2 EX-1.1 d788679dex11.htm EX-1.1 172255
3 EX-5.1 d788679dex51.htm EX-5.1 11849
4 EX-99.1 d788679dex991.htm EX-99.1 7082
5 EX-99.2 d788679dex992.htm EX-99.2 6814
9 GRAPHIC g788679dsp1a.jpg GRAPHIC 6299
10 GRAPHIC g788679dsp2.jpg GRAPHIC 3145
  Complete submission text file 0001193125-25-115946.txt   423412

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA xgn-20250507.xsd EX-101.SCH 2874
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE xgn-20250507_lab.xml EX-101.LAB 17235
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xgn-20250507_pre.xml EX-101.PRE 10829
21 EXTRACTED XBRL INSTANCE DOCUMENT d788679d8k_htm.xml XML 3481
Mailing Address 1261 LIBERTY WAY VISTA CA 92081
Business Address 1261 LIBERTY WAY VISTA CA 92081 (760) 560-1501
EXAGEN INC. (Filer) CIK: 0001274737 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39049 | Film No.: 25925974
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)